Total Funding
90
68
Total FundingPost-IPO Equity raised
Growth Score
18 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
22844
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines.
- Avani V. Kanubaddi: President & COOPast Role: Welmedix Consumer Healthcare, Founder, President & Chief Executive Officer
- Jillian Hagel: Chief Technology Officer
About the Company
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription
medicines to serve these unmet medical needs.
